期刊文献+

Annexin A2及CD_(105)在胰腺导管腺癌中的表达及临床意义

Expression of Annexin A2 and CD_(105) in pancreatic ductal adenocarcinoma and their clinical significance
下载PDF
导出
摘要 目的:探讨Annexin A2(ANXA2,膜联蛋白A2)及CD105在胰腺导管腺癌中表达及两者的相关性。方法采用免疫组织化学染色检测胰腺导管腺癌及癌旁组织中Annexin A2的表达情况及MVD,并对结果进行相关性分析。结果 Annexin A2在肿瘤组织中表达的阳性率显著高于癌旁组织(P<0.05),且癌组织中Annexin A2的表达强度高于癌旁组织(P<0.05)。低分化癌组织Annexin A2表达的阳性率高于高分化和中分化癌组织的阳性率。Annexin A2的表达与癌组织的淋巴转移相关。胰腺导管腺癌组织中的MVD明显高于癌旁组织(P<0.05)。同时, MVD随癌组织分化程度的增高而降低。TNM分期的Ⅲ-Ⅳ期明显高于Ⅰ-Ⅱ期(P<0.05)。CD105标记的MVD与癌组织的淋巴转移相关。Annexin A2染色3+的癌组织MVD明显低于Annexin A2染色0、1+、2+(P<0.05),但Annexin A2染色0、1+、2+的癌组织的MVD表达差异无统计学意义(P=0.615、0.243、0.459)。结论 Annexin A2与CD105在胰腺导管腺癌组织中表达升高,且都与癌组织病理分级及淋巴转移相关。两者具有一定相关性。 Objective To explore the expression of Annexin A2 and CD105 in pancreatic ductal adenocarcinoma(PDAC) tissues and peficancerous tissues and their clinical significance. Methords Using immunohistochemical staining to detect the expression of Annexin A2 and CD105 in pancreatic cancerous tissues and peficancerous tissues, and conduct correlation analysis of results. Results The positive expression rate of Annexin A2 and the MVD in pancreatic ductal adenocarcinoma tissues was higher than that it in peficancerous tissues(P<0.05), the express degree of Annexin A2 in cancerous tissues was higher than it in peficancerous tissues(P<0.05). The expression of Annexin A2 and the MVD were correlated with histological grade and lymphatic metastasis(P<0.05). The MVD of cancerous tissues in clinical stage Ⅲ-Ⅳwas significantly higher than that in clinical stageⅠ-Ⅱ(P<0.05). The MVD of Annexin A2 dyeing 3+cancerous tissue was significantly lower than those in other Annexin A2 dyeing grade(P<0.05). Conclusion The expression of Annexin A2 and CD105 in PDAC is higher than it in peficancerous tissues, and two of both are correlated with hitological grade and lymphatic metastasis. There is correlation in both.
出处 《中国实用医药》 2014年第6期1-4,共4页 China Practical Medicine
关键词 胰腺导管腺癌 ANNEXIN A2 CD105 Pancreatic ductal adenocarcinoma Annexin A2 CD105
  • 相关文献

参考文献14

  • 1Gerke V,Moss SE.Annexins:from structure to function.PhysiolRev,2002,82(2):331-371.
  • 2Vishwanatha J K,Chiang Y,Kumble K D,et al.Enhanced expressionof annexin II in human pancreatic carcinoma cells and primarypancreatic cancers.Carcinogenesis,1993,14(12):2575-2579.
  • 3Domoto T,Miyama Y,Suzuki H,et al.Evaluation of S100A10,annexin II and B-FABP expression as markers for renal cellcarcinoma.Cancer science,2007,98(1):77-82.
  • 4Cougos A,Letarte M.Identification of a human endothelial cellantigen with monoclonal antibody 44G4 produced against a pre-Bleukemic cell line.J Immunol,1988,141(6):1925-1933.
  • 5Tanaka F,Otake Y,Yanagihara K,et al.Correlation betweenapoptotic index and angiogenesis in non-small cell lung cancer:comparison between CD105 and CD34 as a marker of angiogenesis.Lung Cancer,2003,39(3):289-296.
  • 6Chiang Y,Schneiderman MH,Vishwanatha JK.Annexin II expressionis regulated during mammalian cell cycle.Cancer Res,1993,53(24):6017-6021.
  • 7Liemann S,Lewit-Bentley A.Annexins:a novel family of calcium-and membrane-bindingproteins in search of a function.Structure,1995,3(3):233-237.
  • 8Nilius B,Gerke V,Prenen J,et al.Annexin II modulates volume-activated chloride currents in vascular endothelial cells.J BiolChem,1996,271(48):30631-30636.
  • 9Ling Q,Jacovina AT,Deora A,et al.Annexin II regulates fibrinhomeostasis and neoangiogenesis in vivoj Clin Invest,2004,113(1):38-48.
  • 10Tanaka F,Otake Y,Yanagihara K,et al.Evaluation of angiogenesisin non-small cell lung cancer:comparison between anti-CD34antibody and anti-CD 105 antibody.Clin Cancer Res,2001(7):3410.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部